FACTOR VIII DEFICIENCY
Clinical trials for FACTOR VIII DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new FACTOR VIII DEFICIENCY trials appear
Sign up with your email to follow new studies for FACTOR VIII DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly shot may heal swollen joints in hemophilia patients
Disease control Recruiting nowThis study tests whether a once-weekly drug called efanesoctocog alfa can reduce swelling in the joints of people with hemophilia A. About 35 participants aged 12 and older with moderate to severe hemophilia and existing joint swelling will receive the drug for 12 months. The mai…
Matched conditions: FACTOR VIII DEFICIENCY
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated May 16, 2026 12:20 UTC
-
Massive hemophilia registry aims to unlock secrets of bleeding and antibody risks
Knowledge-focused Recruiting nowThis study is a registry that collects medical information from up to 4,000 children with hemophilia A or B across Europe. Researchers will track bleeding episodes, joint health, and the development of antibodies that block treatment. The goal is to better understand the disease …
Matched conditions: FACTOR VIII DEFICIENCY
Sponsor: PedNet Haemophilia Research Foundation • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Massive new study tracks Real-World safety of blood disorder treatments
Knowledge-focused Recruiting nowThis study follows 3,000 people with non-cancer blood disorders (like hemophilia, sickle cell disease, and clotting issues) to see how well treatments work and what side effects occur over time. Researchers will collect safety data, including allergic reactions, infections, and o…
Matched conditions: FACTOR VIII DEFICIENCY
Sponsor: American Thrombosis and Hemostasis Network • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC